Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-24 @ 7:41 PM
NCT ID:
NCT01235403
Eligibility Criteria:
Inclusion Criteria:
* Patient has a diagnosis of partial-onset epilepsy with or without secondary generalization
* Currently taking 1 to 3 concomitant marketed antiepileptic drugs
* 18 years and older at study entry
Exclusion Criteria:
* Previous use of lacosamide
* Hypersensitivity to any component of lacosamide
* Patients with partial onset seizures not clearly identifiable
* History of generalized epilepsy
* History of status epilepticus within last 12 months
* Uncountable seizures due to clustering within last 12 weeks
* Non epileptic events, including pseudoseizures, conversion disorder that could be confused with seizures
* History of drug or alcohol abuse
* History of suicide attempt
* Progressive cerebral disease
* Concomitant treatment of felbamate
* Prior or concomitant vigabatrin use
* Under legal protection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01235403
Study Brief:
Protocol Section:
NCT01235403